Again Acquires Geno to Accelerate Industrial Bioproduction
Le brief IA que les pros lisent chaque soir
Les 7 actus IA du jour, décryptées en 5 min. Gratuit.
Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.
Choisis ton rythme
Gratuit · Pas de spam · Désabonnement en 1 clic
The Danish company Again has acquired the American firm Geno, formerly known as Genomatica. The buyer takes over the AI and computational biotechnology platform of its target, along with patents and datasets. The financial terms are not public. According to Again, this operation significantly strengthens its capabilities and brings together two leading players in industrial biotechnology.
AI Platform, Patents, and Technical Data for Again
Again takes control of the entire artificial intelligence and computational biotechnology platform developed by Geno. According to the Danish company, the operation includes an unmatched patent portfolio, as well as datasets covering experimental results, structural knowledge, scaling-up insights, and development outcomes. Again believes that this technological set greatly enhances its capabilities.
Overview of the Two Companies
Geno is an American biotechnology company, previously known as Genomatica. Again, a technology company based in Denmark, designs multi-feedstock production pathways and ensures their industrial scaling. These processes are used to manufacture essential products for the functioning of the global economy.
Terms and Scope of the Operation
The financial details of the transaction have not been disclosed. The acquisition could be among the most significant consolidations in the industrial biotechnology sector. Again claims that the operation brings together two of the most advanced companies in the field into a single entity.
Brief IA — L'actualité IA en français
L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.